FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results.
EUROPEAN JOURNAL OF CANCER（2000）
关键词
advanced breast cancer chemotherapy,mitomycin-C drug combination,epidoxorubicin drug combination,lonidamine and breast cancer,lonidamine therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要